GSK Ireland plant gets warning letter; Georgia builds training center for Baxter plant; GSK expands North Carolina production;

> A GlaxoSmithKline ($GSK) plant in Ireland has received a warning letter. Letter

> Georgia started work on a state-funded training center on the grounds of a new Baxter International plant in East Georgia, part of the incentives to get Baxter to build the $1 billion facility there. Story

> GlaxoSmithKline ($GSK) is hiring 60 to 75 people at its plant in Zebulon, NC, as it ramps up production there of its new generation Ellipta Diskus inhaler and of painkiller Panadol. Story

> The FDA approved a new bulk manufacturing suite at Pacira Pharmaceuticals facility in San Diego, CA, where it manufacturers its analgesic Exparel. Release

> Brazil's ANVISA is now expecting drug manufacturers there to give it at least a year's notice of any intent to discontinue making a product so it can prepare for potential shortages. Story

> France has granted a tax designation to Cobra Biologics through 2015 which extends to any customers of its antibody and recombinant protein services. Release

And Finally... Pharmaceutical manufacturing lags behind only leather processing in India as the leading employer in manufacturing. Story